| Nov 13 |
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
|
| Nov 12 |
Scholar Rock Holding Corporation (SRRK) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Scholar Rock GAAP EPS of -$0.66 misses by $0.06
|
| Nov 12 |
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 4 |
Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin
|
| Nov 1 |
Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
|
| Oct 31 |
Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
|
| Oct 25 |
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
|
| Oct 22 |
Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
|
